The global CAR T-cell therapy market is witnessing exponential growth, driven by increasing incidence of cancer and favorable regulatory policies. Leading players in the market are investing in development to broaden their product portfolio and meet the growing demand for effective cancer treatments. Furthermore, advancements in CAR T-cell therapy